Piramal Pharma Limited (PPL) announced an investment of INR101.77 cr in Yapan Bio Pvt Ltd (Yapan) of Hyderabad, India, augmenting the capabilities of its Contract Development and Manufacturing Organization (CDMO) business, Piramal Pharma Solutions (PPS). PPL holds 27.78% equity stake in the company as a result of this investment, according to the statement. As PPS continues…